KalVista Pharmaceuticals
Why Robinhood?
You can watch KALV and buy or sell other stocks, ETFs, and their options commission-free!About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
With a market cap of 1.38B, KalVista Pharmaceuticals(KALV) trades at $27.00. The stock has a price-to-earnings ratio of -6.75.
KalVista Pharmaceuticals(KALV) stock opened on 2026-08-11 at —. The price climbed to — and dipped to —.
KalVista Pharmaceuticals(KALV) shares are trading with a volume of 0, against a daily average of 951.76K.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $27.00 and a 52-week low of $9.83.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $27.00 and a 52-week low of $9.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.